Atlas Trials

64Cu-SAR-bisPSMA Positron Emission Tomography of Patients With Known or Suspected Prostate Cancer

Clinical trial NCT05286840 · UNKNOWN

Trial details

NCT number
NCT05286840
Sponsor
Luke Nordquist, MD
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2022-03-28
Primary completion
2023-03-28
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.